Eli Lilly & Co $61.06

down -1.56


31/7/2014 04:00 PM  |  NYSE : LLY  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get LLY Trend Analysis - it has underperformed the S&P 500 by 0%

Partner Headlines

  1. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  2. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties

    Benzinga
  3. Thursday Morning Earnings Reports

    Benzinga
  4. Earnings Scheduled For July 24, 2014

    Benzinga
  5. New Study Shows Beta-Amyloid Imaging Is Associated With Altered Diagnosis ...

    Benzinga
  6. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover And Co-Develop ...

    Benzinga
  7. Benzinga's Top #PreMarket Gainers

    Benzinga
  8. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  9. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  10. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  11. Benzinga's Top Upgrades

    Benzinga
  12. Eli Lilly is on the Right Track

    GuruFocus
  13. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  14. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  15. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  16. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  17. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  18. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  19. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent Activity

    Benzinga
  20. Eli Lilly insulin trial succeeds

    IBD
  21. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  22. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  23. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  24. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared to Insulin ...

    Benzinga
  25. Can Pfizer Make Up Its Loss?

    GuruFocus
  26. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  27. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  28. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  29. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  30. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  31. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  32. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  33. Actavis Earns Over-The-Top Q1

    IBD
  34. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  35. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  36. China Rule Change Further Opens Yuan To World Markets

    IBD
  37. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus
  38. Drugmakers' Q1 was anemic

    IBD
  39. Eli Lilly Jr. Made His Firm A Pharmaceutical Power

    IBD
  40. Earnings Scheduled For April 24, 2014

    Benzinga
  41. Big Pharmas Swap Specialties

    IBD
  42. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  43. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  44. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  45. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  46. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  47. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  48. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  49. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  50. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
Trading Center